@dr_monga77

Dr. Monga is the SVC Endowed Chair in Pathobiology & Therapeutics & the Director of OPTIn and the Pittsburgh Liver Research Center

 University of Pittsburgh
livercenter.pitt.edu/people/paul-monga-md/
Joined April 2016
  • Tweets49
  • Following24
  • Followers100
2Media
inside.upmc.com/71041-2/

Pitt-UPMC collaboration transforms liver cancer care from lab bench to patient bedside - UPMC &...

Dr. Satdarshan (Paul) Singh Monga has a personal connection to… Read more

inside.upmc.com
2
1
144
Developed a mutated beta-catenin gene signature for detection of CTNNB1 mutations using transcriptomic and spatial transcriptomic data sciencedirect.com/science/ar…
1
7
1,238
Dr. Monga retweeted
PLRC@PLRC_PittLiver30 Apr 2024
Dr. Sarah Taylor, Children’s Hospital Colorado, delivering a highly informative seminar on her research, “Identifying immune-metabolic targets to modulate hepatic macrophage function and improve patient outcomes in biliary atresia”. Thank you Dr. Taylor!
1
8
465
Great talk by HMS Director of the Harvard-MIT Division of Health Sciences and Technology and Chief of the Gastroenterology Division at the Massachusetts General Hospital Dr. Wolfram Goessling 🙌 #plrc
3
6
477
Dr. Monga retweeted
PLRC@PLRC_PittLiver20 Oct 2023
Having fun at last month’s K-Club social hour. Dr. Monga casually informing on the opportunities and benefits for junior faculty and post-docs.
2
5
465
Dr. Monga retweeted
PLRC@PLRC_PittLiver10 Oct 2023
Excited to host our PLRC SIG “Injury” again. Featuring a scientist physician round table on cholangiopathy with Drs. Jonassaint and Nejak-Bowen
1
5
403
Dr. Monga retweeted
PLRC@PLRC_PittLiver17 Oct 2023
Looking forward to an exciting day at the PLRC/PLI annual retreat! – at Pittsburgh, PA
3
11
542
Dr. Monga retweeted
PLRC@PLRC_PittLiver17 Oct 2023
Drs. Monga and Nejak-Bowen starting off the annual retreat by informing on resources and successes of the PLRC. – at Pittsburgh, PA
5
1
12
1,223
Dr. Monga retweeted
PLRC@PLRC_PittLiver17 Oct 2023
Highly informative morning session featuring updates from P&F recipients and PLRC core updates. – at Pittsburgh, PA
4
6
629
⁦@DrPMonga⁩ ⁦@PLRC_PittLiver⁩ discussing new Pittsburgh liver institute aiming to address models from animals to advanced human models #organoids spectra of pipeline from preclinical to clinical stages… Stay tuned!
3
18
994
Dr. Monga retweeted
PLRC@PLRC_PittLiver17 Oct 2023
Wonderful keynote lecture on the impact of lipids and cholesterol on hepatocyte and liver mechanics by Becky Wells, UPenn. – at Pittsburgh, PA
4
7
530
Dr. Monga retweeted
PLRC@PLRC_PittLiver18 Oct 2023
Incredible scientific diversity, showcasing innovative approaches, technologies and resources of the PLRC/PLI during the afternoon session of the retreat.
4
9
627
Dr. Monga retweeted
PLRC@PLRC_PittLiver18 Oct 2023
Closing out the day with vigorous discussion at the poster session. #liverlovers
5
9
549
Very proud of Laura Molina, my MSTP who just started residency in Pathology at UPMC. Laura published her first senior author manuscript "Loss of TAZ after YAP deletion severely impairs foregut development and worsens cholestatic hepatocellular injury" pubmed.ncbi.nlm.nih.gov/3755…

Loss of TAZ after YAP deletion severely impairs foregut development and worsens cholestatic...

YAP loss (with or without TAZ loss) aborts biliary development. YAP and TAZ play a codependent critical role in foregut endoderm development outside the liver, but they are not essential for hepato...

pubmed.ncbi.nlm.nih.gov
17
374
I’m happy to share that I’m starting a new position as Director: Pittsburgh Liver Institute at University of Pittsburgh School of Medicine! lnkd.in/eiKmDE4i
9
1
3
68
6,952
Thanks for the support of outstanding scientists, physicians, physician-scientists band patients that have made this a meaningful journey and enabled this initiative. Thanks to the leadership for the vote of confidence. I look forw…lnkd.in/gSgihe_8 lnkd.in/gjViYBTy

Thanks for the support of outstanding scientists, physicians, physician-scientists and patients...

Thanks for the support of outstanding scientists, physicians, physician-scientists and patients that have made this a meaningful journey and enabled this initiative. Thanks to the leadership for the...

linkedin.com
8
3
38
3,320
Inhibition of Heat Shock Factor 1 Signaling Decreases Hepatoblastoma Growth via Induction of Apoptosis ajp.amjpathol.org/article/S0…

Inhibition of Heat Shock Factor 1 Signaling Decreases Hepatoblastoma Growth via Induction of...

Although rare compared with adult liver cancers, hepatoblastoma (HB) is the most common pediatric liver malignancy, and its incidence is increasing. Currently, the treatment includes surgical...

ajp.amjpathol.org
1
68
Helping the liver regenerate itself could give patients with end-stage liver disease a treatment option besides waiting for a transplant theconversation.com/helping-… via @ConversationUS

Helping the liver regenerate itself could give patients with end-stage liver disease a treatment...

Liver transplant waitlists can range from 30 days to over five years. Developing treatments that spur liver regeneration could help reduce demand for scarce organs.

theconversation.com
1
Load more